https://www.selleckchem.com/products/fadraciclib.html In head and neck cancer management, there is a need for tailored approaches to optimally implement clinical outcomes. Based on the assumption that efficacy and long-term toxicity are not satisfactory for standard concurrent platinum-based chemoradiotherapy, several trials have been designed to test whether induction immunotherapy and/or concomitant immunotherapy and radiotherapy result in improved survival and toxicity outcomes. Here, we present an overview of the most recent concomitant therapeutic strategies for head and neck cancer, focusing on the knowledge available regarding check-point inhibitors. The aim is to present the characteristics of the main check-point inhibitors and to summarize the clinical trials on the combination of immune check-point inhibitors and (chemo)radiotherapy in the definitive HNC setting, in order to provide a useful clinical tool for further research.Since late 2019, Coronavirus Disease 2019 (COVID-19) has spread all over the world. The disease is highly contagious, and it may lead to acute respiratory distress (ARD). Medical imaging can play an important role in classifying, detecting, and measuring the severity of the virus. This study aims to provide a novel auto-detection tool that can detect abnormal changes in conventional X-ray images for confirmed COVID-19 cases. X-ray images from patients diagnosed with COVID-19 were converted into 19 different colored layers. Each layer represented objects with similar contrast that could be defined as a specific color. The objects with similar contrasts were formed in a single layer. All the objects from all the layers were extracted as a single-color image. Based on the differentiation of colors, the prototype model was able to recognize a wide spectrum of abnormal changes in the image texture. This was true even if there was minimal variation of the contrast values of the detected uncleared abnormalities. The results indicate that th